FRIDAY HEALTH REPORT: Peptides sold online without FDA approval may soon be available by prescriptionWASHINGTON — An FDA advisory panel is reviewing whether compounding pharmacies should be allowed to manufacture seven specific peptides, which could make them easier to access in the United States. Right now, substances like BPC-157 and TB-500 are being obtained on the gray market, typically through online sellers or social media. These substances are often promoted online as a way to support muscle and tissue healing. What federal officials are now weighing is whether Americans should be able to access these products through prescriptions from compounding pharmacies. So far, the panel has voted in favor of making some of these peptides more accessible, Youri Benadjaoud of ABC News said, "though ultimately the final decision will be up to FDA leadership."